These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6682924)

  • 21. Differential modification of opiate receptor activity by arylsulfatase treatment.
    Garzón J; Jen MF; Lee NM
    Biochem Pharmacol; 1983 May; 32(9):1523-8. PubMed ID: 6134534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible non-narcotic component to action of opiate peptides on tonic immobility.
    Olson RD; Kastin AJ; Lahoste GJ; Olson GA; Coy DH
    Pharmacol Biochem Behav; 1979 Dec; 11(6):705-8. PubMed ID: 538059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Opioid activity of peptides and wound healing of the skin].
    Vinogradov VA; Spevak SE; Iarygin KN; Korobov NV; Solov'eva AI
    Biull Eksp Biol Med; 1987 Jul; 104(7):89-91. PubMed ID: 3040149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerance to morphine bradycardia in the rat.
    Kiang JG; Dewey WL; Wei ET
    J Pharmacol Exp Ther; 1983 Jul; 226(1):187-91. PubMed ID: 6864538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of stress-induced hyperglycemia by tail pinching or intraventricular enkephalin administration in the rat.
    Sanchez R; Vargas L
    Brain Res; 1988 Jun; 452(1-2):149-55. PubMed ID: 3042094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the opiate antagonist naloxone and the enkephalin analog DAMME on the vasopressin response to a hypertonic stimulus in man.
    Lightman SL; Langdon N; Forsling ML
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1447-9. PubMed ID: 7440706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible regulatory role of dynorphin-(1-13) on narcotic-induced changes in naloxone efficacy.
    Tulunay FC; Jen MF; Chang JK; Loh HH; Lee NM
    Eur J Pharmacol; 1981 Dec; 76(2-3):235-9. PubMed ID: 6277644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of met-enkephalin on human spermatozoa and evidence for its physiological role.
    Foresta C; Caretto A; Indino M; Betterle C; Scandellari C
    Arch Androl; 1986; 17(1):19-24. PubMed ID: 3539053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    Latimer LG; Duffy P; Kalivas PW
    J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous opioids and baroreflex control in humans.
    Rubin PC; McLean K; Reid JL
    Hypertension; 1983; 5(4):535-8. PubMed ID: 6862578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central and peripheral sites of action for the protective effect of opioids of the rat stomach.
    Ferri S; Arrigo-Reina R; Candeletti S; Costa G; Murari G; Speroni E; Scoto G
    Pharmacol Res Commun; 1983 Apr; 15(4):409-18. PubMed ID: 6306698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of opioid peptides on respiration and analgesia in rats.
    Flórez J; Pazos A
    Life Sci; 1982 Sep 20-27; 31(12-13):1275-7. PubMed ID: 6292613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central cardiovascular actions of D-Ala2-Met5-enkephalinamide in the rat: effects of naloxone and nucleus reticularis gigantocellularis lesion.
    Wong TM; Chan SH; Tse SY
    Neurosci Lett; 1984 May; 46(3):249-54. PubMed ID: 6377125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for the participation of endogenous opioids in the sympathoadrenal response to hypoglycaemia in man.
    Bouloux PM; Grossman A; Lytras N; Besser GM
    Clin Endocrinol (Oxf); 1985 Jan; 22(1):49-56. PubMed ID: 3884188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feedback inhibition of met-enkephalin release from the rat spinal cord in vivo.
    Collin E; Bourgoin S; Mantelet S; Hamon M; Cesselin F
    Synapse; 1992 May; 11(1):76-84. PubMed ID: 1604425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACTH1-24 counteracts the prolactin-releasing effect of an opioid.
    Ferri S; Cocchi D; Locatelli V; Spampinato S; Muller E
    Eur J Pharmacol; 1982 Jan; 77(2-3):143-5. PubMed ID: 6277660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of opiate peptides on interneuronal transmission in the spinal cord].
    Aliautdin RN; Kasparov SA; Fisenko VP; Chicehnkov ON
    Farmakol Toksikol; 1981; 44(4):406-10. PubMed ID: 6269876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory responses to opiates applied to the medullary ventral surface.
    Flórez J; Hurlé MA; Mediavilla A
    Life Sci; 1982 Nov 15-22; 31(20-21):2189-92. PubMed ID: 6819420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of naloxone and opioid agonists on gastric excitatory responses to stimulation of the vagus nerve in cats.
    Okamoto T; Kurahashi K; Fujiwara M
    Br J Pharmacol; 1988 Oct; 95(2):329-34. PubMed ID: 2906554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exocrine pancreatic secretion in dogs: effects of the synthetic methionine-enkephalin analog FK 33-824 and opioid-receptor antagonist naloxone.
    Triebling AT; Koller M; Toth LS; Dreiling DA
    Mt Sinai J Med; 1986 May; 53(5):340-2. PubMed ID: 3489174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.